Report Scope & Overview:
RNA Medicine Market size generated $4,938.38 Million in 2021, and is projected to reach $25,121.95 Million by 2030, growing at a CAGR of 17.6% from 2021 to 2030.
RNA Medicine Market Overview:
Global RNA Medicine Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. RNA Medicine Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Overall, RNA Medicine market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, RNA Medicine market research is expected to experience further growth and innovation in the coming years.
Global RNA Medicine Market: By Company
• Pfizer
• Roche
• Sanofi-Aventis
• Abbott Laboratories
• Arrowhead Pharmaceuticals
• Benitec Biopharma
• Calimmune Inc
• Dicerna
• Gradalis
• Quark
• RXi
• Senesco
• Silence Therapeutics
• Silenseed
• Tekmira
• Alnylam Pharmaceuticals
Global RNA Medicine Market: By Type
• siRNA
• ASO
• miRNA
• Nucleic Acid Aptamers
Global RNA Medicine Market: By Application
• Cancer
• Diabetes
• Tuberculosis
• Cardiovascular Diseases
• Others
Global RNA Medicine Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global RNA Medicine market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Reasons to Purchase RNA Medicine Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Overall, market research reports provide businesses and organizations with valuable information that can help them make informed decisions and stay competitive in their industry. They can provide a solid foundation for business planning, strategy development, and decision-making.
Objectives of RNA Medicine Market Study:
The objectives of RNA Medicine market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of RNA Medicine market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Overall, the objectives of RNA Medicine market research report are to provide businesses and organizations with valuable insights and data-driven recommendations that can help them make informed business decisions and stay competitive in their industry.
Global RNA Medicine Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. RNA Medicine Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Overall, RNA Medicine market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, RNA Medicine market research is expected to experience further growth and innovation in the coming years.
DESCIMG1
RNA Medicine Market Key Drivers
Advancements in RNA Therapeutics: Significant advancements in the understanding of RNA biology and the development of innovative RNA-based therapeutics, such as small interfering RNAs (siRNAs), messenger RNAs (mRNAs), and antisense oligonucleotides (ASOs), are driving the growth of the RNA medicine market.
Precision Medicine and Personalized Therapies: RNA medicines offer the potential for precise targeting of specific genes or disease-causing factors, enabling the development of personalized therapies tailored to an individual's genetic profile and disease characteristics.
Emergence of mRNA Vaccines: The success of mRNA-based COVID-19 vaccines has highlighted the potential of mRNA therapeutics. This success has generated interest in the development of mRNA-based vaccines and therapies for various diseases beyond infectious diseases.
Treatment of Previously Intractable Diseases: RNA medicines are showing promise in treating diseases that were traditionally difficult to target with conventional therapies, such as genetic disorders, rare diseases, and certain types of cancers.
RNA Interference (RNAi) Technology: The development of RNAi technology has enabled the silencing of specific genes responsible for diseases. This technology has opened up new avenues for targeting a wide range of diseases at the genetic level.
Market Segmentations:Global RNA Medicine Market: By Company
• Pfizer
• Roche
• Sanofi-Aventis
• Abbott Laboratories
• Arrowhead Pharmaceuticals
• Benitec Biopharma
• Calimmune Inc
• Dicerna
• Gradalis
• Quark
• RXi
• Senesco
• Silence Therapeutics
• Silenseed
• Tekmira
• Alnylam Pharmaceuticals
Global RNA Medicine Market: By Type
• siRNA
• ASO
• miRNA
• Nucleic Acid Aptamers
Global RNA Medicine Market: By Application
• Cancer
• Diabetes
• Tuberculosis
• Cardiovascular Diseases
• Others
Global RNA Medicine Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global RNA Medicine market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
| Report Attribute/Metric | Details |
| Market Size 2021 | $4,938.38 Million |
| Market Size 2030 | $25,121.95 Million |
| Compound Annual Growth Rate (CAGR) | 17.6%(2021-2030) |
| Base Year | 2022 |
| Forecast Period | 2023-2032 |
| Historical Data | 2018-2022 |
| Forecast Units | Value ($ Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | • siRNA • ASO • miRNA • Nucleic Acid Aptamers |
| By Application | • Cancer • Diabetes • Tuberculosis • Cardiovascular Diseases |
| Key Companies Profiled | • Pfizer • Roche • Sanofi-Aventis • Abbott Laboratories • Arrowhead Pharmaceuticals • Benitec Biopharma • Calimmune Inc • Dicerna • Gradalis • Quark • RXi • Senesco • Silence Therapeutics • Silenseed • Tekmira • Alnylam Pharmaceuticals |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Reasons to Purchase RNA Medicine Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Overall, market research reports provide businesses and organizations with valuable information that can help them make informed decisions and stay competitive in their industry. They can provide a solid foundation for business planning, strategy development, and decision-making.
Objectives of RNA Medicine Market Study:
The objectives of RNA Medicine market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of RNA Medicine market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Overall, the objectives of RNA Medicine market research report are to provide businesses and organizations with valuable insights and data-driven recommendations that can help them make informed business decisions and stay competitive in their industry.
Frequently Asked Questions
RNA Medicine Market size generated $4,938.38 Million in 2021, and is projected to reach $25,121.95 Million by 2030, growing at a CAGR of 17.6% from 2021 to 2030.
Key drivers include advancements in RNA therapeutics, the success of mRNA vaccines, the potential for personalized therapies, the rise of RNA interference (RNAi) technology, and increased investment and partnerships in the field.
The success of mRNA-based COVID-19 vaccines highlighted the potential of mRNA therapeutics, driving interest and investment in the development of mRNA-based therapies for various diseases.
Collaborations between pharmaceutical companies, biotechnology firms, and academic institutions are accelerating research and development efforts in RNA-based therapeutics, facilitating the sharing of expertise and resources.
TABLE OF CONTENT
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Medicine Market Size Growth Rate by Type: 2018 VS 2023 VS 2032
1.2.2 siRNA
1.2.3 ASO
1.2.4 miRNA
1.2.5 Nucleic Acid Aptamers
1.3 Market by Application
1.3.1 Global RNA Medicine Market Growth by Application: 2018 VS 2023 VS 2032
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Medicine Market Perspective (2017-2032)
2.2 RNA Medicine Growth Trends by Region
2.2.1 Global RNA Medicine Market Size by Region: 2018 VS 2023 VS 2032
2.2.2 RNA Medicine Historic Market Size by Region (2017-2023)
2.2.3 RNA Medicine Forecasted Market Size by Region (2023-2032)
2.3 RNA Medicine Market Dynamics
2.3.1 RNA Medicine Industry Trends
2.3.2 RNA Medicine Market Drivers
2.3.3 RNA Medicine Market Challenges
2.3.4 RNA Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Medicine Players by Revenue
3.1.1 Global Top RNA Medicine Players by Revenue (2017-2023)
3.1.2 Global RNA Medicine Revenue Market Share by Players (2017-2023)
3.2 Global RNA Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA Medicine Revenue
3.4 Global RNA Medicine Market Concentration Ratio
3.4.1 Global RNA Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Medicine Revenue in 2022
3.5 RNA Medicine Key Players Head office and Area Served
3.6 Key Players RNA Medicine Product Solution and Service
3.7 Date of Enter into RNA Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Medicine Breakdown Data by Type
4.1 Global RNA Medicine Historic Market Size by Type (2017-2023)
4.2 Global RNA Medicine Forecasted Market Size by Type (2023-2032)
5 RNA Medicine Breakdown Data by Application
5.1 Global RNA Medicine Historic Market Size by Application (2017-2023)
5.2 Global RNA Medicine Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America RNA Medicine Market Size (2017-2032)
6.2 North America RNA Medicine Market Growth Rate by Country: 2018 VS 2023 VS 2032
6.3 North America RNA Medicine Market Size by Country (2017-2023)
6.4 North America RNA Medicine Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Medicine Market Size (2017-2032)
7.2 Europe RNA Medicine Market Growth Rate by Country: 2018 VS 2023 VS 2032
7.3 Europe RNA Medicine Market Size by Country (2017-2023)
7.4 Europe RNA Medicine Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Medicine Market Size (2017-2032)
8.2 Asia-Pacific RNA Medicine Market Growth Rate by Region: 2018 VS 2023 VS 2032
8.3 Asia-Pacific RNA Medicine Market Size by Region (2017-2023)
8.4 Asia-Pacific RNA Medicine Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Medicine Market Size (2017-2032)
9.2 Latin America RNA Medicine Market Growth Rate by Country: 2018 VS 2023 VS 2032
9.3 Latin America RNA Medicine Market Size by Country (2017-2023)
9.4 Latin America RNA Medicine Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Medicine Market Size (2017-2032)
10.2 Middle East & Africa RNA Medicine Market Growth Rate by Country: 2018 VS 2023 VS 2032
10.3 Middle East & Africa RNA Medicine Market Size by Country (2017-2023)
10.4 Middle East & Africa RNA Medicine Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer RNA Medicine Introduction
11.1.4 Pfizer Revenue in RNA Medicine Business (2017-2023)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche RNA Medicine Introduction
11.2.4 Roche Revenue in RNA Medicine Business (2017-2023)
11.2.5 Roche Recent Development
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Company Detail
11.3.2 Sanofi-Aventis Business Overview
11.3.3 Sanofi-Aventis RNA Medicine Introduction
11.3.4 Sanofi-Aventis Revenue in RNA Medicine Business (2017-2023)
11.3.5 Sanofi-Aventis Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories RNA Medicine Introduction
11.4.4 Abbott Laboratories Revenue in RNA Medicine Business (2017-2023)
11.4.5 Abbott Laboratories Recent Development
11.5 Arrowhead Pharmaceuticals
11.5.1 Arrowhead Pharmaceuticals Company Detail
11.5.2 Arrowhead Pharmaceuticals Business Overview
11.5.3 Arrowhead Pharmaceuticals RNA Medicine Introduction
11.5.4 Arrowhead Pharmaceuticals Revenue in RNA Medicine Business (2017-2023)
11.5.5 Arrowhead Pharmaceuticals Recent Development
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Company Detail
11.6.2 Benitec Biopharma Business Overview
11.6.3 Benitec Biopharma RNA Medicine Introduction
11.6.4 Benitec Biopharma Revenue in RNA Medicine Business (2017-2023)
11.6.5 Benitec Biopharma Recent Development
11.7 Calimmune Inc
11.7.1 Calimmune Inc Company Detail
11.7.2 Calimmune Inc Business Overview
11.7.3 Calimmune Inc RNA Medicine Introduction
11.7.4 Calimmune Inc Revenue in RNA Medicine Business (2017-2023)
11.7.5 Calimmune Inc Recent Development
11.8 Dicerna
11.8.1 Dicerna Company Detail
11.8.2 Dicerna Business Overview
11.8.3 Dicerna RNA Medicine Introduction
11.8.4 Dicerna Revenue in RNA Medicine Business (2017-2023)
11.8.5 Dicerna Recent Development
11.9 Gradalis
11.9.1 Gradalis Company Detail
11.9.2 Gradalis Business Overview
11.9.3 Gradalis RNA Medicine Introduction
11.9.4 Gradalis Revenue in RNA Medicine Business (2017-2023)
11.9.5 Gradalis Recent Development
11.10 Quark
11.10.1 Quark Company Detail
11.10.2 Quark Business Overview
11.10.3 Quark RNA Medicine Introduction
11.10.4 Quark Revenue in RNA Medicine Business (2017-2023)
11.10.5 Quark Recent Development
11.11 RXi
11.11.1 RXi Company Detail
11.11.2 RXi Business Overview
11.11.3 RXi RNA Medicine Introduction
11.11.4 RXi Revenue in RNA Medicine Business (2017-2023)
11.11.5 RXi Recent Development
11.12 Senesco
11.12.1 Senesco Company Detail
11.12.2 Senesco Business Overview
11.12.3 Senesco RNA Medicine Introduction
11.12.4 Senesco Revenue in RNA Medicine Business (2017-2023)
11.12.5 Senesco Recent Development
11.13 Silence Therapeutics
11.13.1 Silence Therapeutics Company Detail
11.13.2 Silence Therapeutics Business Overview
11.13.3 Silence Therapeutics RNA Medicine Introduction
11.13.4 Silence Therapeutics Revenue in RNA Medicine Business (2017-2023)
11.13.5 Silence Therapeutics Recent Development
11.14 Silenseed
11.14.1 Silenseed Company Detail
11.14.2 Silenseed Business Overview
11.14.3 Silenseed RNA Medicine Introduction
11.14.4 Silenseed Revenue in RNA Medicine Business (2017-2023)
11.14.5 Silenseed Recent Development
11.15 Tekmira
11.15.1 Tekmira Company Detail
11.15.2 Tekmira Business Overview
11.15.3 Tekmira RNA Medicine Introduction
11.15.4 Tekmira Revenue in RNA Medicine Business (2017-2023)
11.15.5 Tekmira Recent Development
11.16 Alnylam Pharmaceuticals
11.16.1 Alnylam Pharmaceuticals Company Detail
11.16.2 Alnylam Pharmaceuticals Business Overview
11.16.3 Alnylam Pharmaceuticals RNA Medicine Introduction
11.16.4 Alnylam Pharmaceuticals Revenue in RNA Medicine Business (2017-2023)
11.16.5 Alnylam Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Medicine Market Size Growth Rate by Type: 2018 VS 2023 VS 2032
1.2.2 siRNA
1.2.3 ASO
1.2.4 miRNA
1.2.5 Nucleic Acid Aptamers
1.3 Market by Application
1.3.1 Global RNA Medicine Market Growth by Application: 2018 VS 2023 VS 2032
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Medicine Market Perspective (2017-2032)
2.2 RNA Medicine Growth Trends by Region
2.2.1 Global RNA Medicine Market Size by Region: 2018 VS 2023 VS 2032
2.2.2 RNA Medicine Historic Market Size by Region (2017-2023)
2.2.3 RNA Medicine Forecasted Market Size by Region (2023-2032)
2.3 RNA Medicine Market Dynamics
2.3.1 RNA Medicine Industry Trends
2.3.2 RNA Medicine Market Drivers
2.3.3 RNA Medicine Market Challenges
2.3.4 RNA Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Medicine Players by Revenue
3.1.1 Global Top RNA Medicine Players by Revenue (2017-2023)
3.1.2 Global RNA Medicine Revenue Market Share by Players (2017-2023)
3.2 Global RNA Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA Medicine Revenue
3.4 Global RNA Medicine Market Concentration Ratio
3.4.1 Global RNA Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Medicine Revenue in 2022
3.5 RNA Medicine Key Players Head office and Area Served
3.6 Key Players RNA Medicine Product Solution and Service
3.7 Date of Enter into RNA Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Medicine Breakdown Data by Type
4.1 Global RNA Medicine Historic Market Size by Type (2017-2023)
4.2 Global RNA Medicine Forecasted Market Size by Type (2023-2032)
5 RNA Medicine Breakdown Data by Application
5.1 Global RNA Medicine Historic Market Size by Application (2017-2023)
5.2 Global RNA Medicine Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America RNA Medicine Market Size (2017-2032)
6.2 North America RNA Medicine Market Growth Rate by Country: 2018 VS 2023 VS 2032
6.3 North America RNA Medicine Market Size by Country (2017-2023)
6.4 North America RNA Medicine Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Medicine Market Size (2017-2032)
7.2 Europe RNA Medicine Market Growth Rate by Country: 2018 VS 2023 VS 2032
7.3 Europe RNA Medicine Market Size by Country (2017-2023)
7.4 Europe RNA Medicine Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Medicine Market Size (2017-2032)
8.2 Asia-Pacific RNA Medicine Market Growth Rate by Region: 2018 VS 2023 VS 2032
8.3 Asia-Pacific RNA Medicine Market Size by Region (2017-2023)
8.4 Asia-Pacific RNA Medicine Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Medicine Market Size (2017-2032)
9.2 Latin America RNA Medicine Market Growth Rate by Country: 2018 VS 2023 VS 2032
9.3 Latin America RNA Medicine Market Size by Country (2017-2023)
9.4 Latin America RNA Medicine Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Medicine Market Size (2017-2032)
10.2 Middle East & Africa RNA Medicine Market Growth Rate by Country: 2018 VS 2023 VS 2032
10.3 Middle East & Africa RNA Medicine Market Size by Country (2017-2023)
10.4 Middle East & Africa RNA Medicine Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer RNA Medicine Introduction
11.1.4 Pfizer Revenue in RNA Medicine Business (2017-2023)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche RNA Medicine Introduction
11.2.4 Roche Revenue in RNA Medicine Business (2017-2023)
11.2.5 Roche Recent Development
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Company Detail
11.3.2 Sanofi-Aventis Business Overview
11.3.3 Sanofi-Aventis RNA Medicine Introduction
11.3.4 Sanofi-Aventis Revenue in RNA Medicine Business (2017-2023)
11.3.5 Sanofi-Aventis Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories RNA Medicine Introduction
11.4.4 Abbott Laboratories Revenue in RNA Medicine Business (2017-2023)
11.4.5 Abbott Laboratories Recent Development
11.5 Arrowhead Pharmaceuticals
11.5.1 Arrowhead Pharmaceuticals Company Detail
11.5.2 Arrowhead Pharmaceuticals Business Overview
11.5.3 Arrowhead Pharmaceuticals RNA Medicine Introduction
11.5.4 Arrowhead Pharmaceuticals Revenue in RNA Medicine Business (2017-2023)
11.5.5 Arrowhead Pharmaceuticals Recent Development
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Company Detail
11.6.2 Benitec Biopharma Business Overview
11.6.3 Benitec Biopharma RNA Medicine Introduction
11.6.4 Benitec Biopharma Revenue in RNA Medicine Business (2017-2023)
11.6.5 Benitec Biopharma Recent Development
11.7 Calimmune Inc
11.7.1 Calimmune Inc Company Detail
11.7.2 Calimmune Inc Business Overview
11.7.3 Calimmune Inc RNA Medicine Introduction
11.7.4 Calimmune Inc Revenue in RNA Medicine Business (2017-2023)
11.7.5 Calimmune Inc Recent Development
11.8 Dicerna
11.8.1 Dicerna Company Detail
11.8.2 Dicerna Business Overview
11.8.3 Dicerna RNA Medicine Introduction
11.8.4 Dicerna Revenue in RNA Medicine Business (2017-2023)
11.8.5 Dicerna Recent Development
11.9 Gradalis
11.9.1 Gradalis Company Detail
11.9.2 Gradalis Business Overview
11.9.3 Gradalis RNA Medicine Introduction
11.9.4 Gradalis Revenue in RNA Medicine Business (2017-2023)
11.9.5 Gradalis Recent Development
11.10 Quark
11.10.1 Quark Company Detail
11.10.2 Quark Business Overview
11.10.3 Quark RNA Medicine Introduction
11.10.4 Quark Revenue in RNA Medicine Business (2017-2023)
11.10.5 Quark Recent Development
11.11 RXi
11.11.1 RXi Company Detail
11.11.2 RXi Business Overview
11.11.3 RXi RNA Medicine Introduction
11.11.4 RXi Revenue in RNA Medicine Business (2017-2023)
11.11.5 RXi Recent Development
11.12 Senesco
11.12.1 Senesco Company Detail
11.12.2 Senesco Business Overview
11.12.3 Senesco RNA Medicine Introduction
11.12.4 Senesco Revenue in RNA Medicine Business (2017-2023)
11.12.5 Senesco Recent Development
11.13 Silence Therapeutics
11.13.1 Silence Therapeutics Company Detail
11.13.2 Silence Therapeutics Business Overview
11.13.3 Silence Therapeutics RNA Medicine Introduction
11.13.4 Silence Therapeutics Revenue in RNA Medicine Business (2017-2023)
11.13.5 Silence Therapeutics Recent Development
11.14 Silenseed
11.14.1 Silenseed Company Detail
11.14.2 Silenseed Business Overview
11.14.3 Silenseed RNA Medicine Introduction
11.14.4 Silenseed Revenue in RNA Medicine Business (2017-2023)
11.14.5 Silenseed Recent Development
11.15 Tekmira
11.15.1 Tekmira Company Detail
11.15.2 Tekmira Business Overview
11.15.3 Tekmira RNA Medicine Introduction
11.15.4 Tekmira Revenue in RNA Medicine Business (2017-2023)
11.15.5 Tekmira Recent Development
11.16 Alnylam Pharmaceuticals
11.16.1 Alnylam Pharmaceuticals Company Detail
11.16.2 Alnylam Pharmaceuticals Business Overview
11.16.3 Alnylam Pharmaceuticals RNA Medicine Introduction
11.16.4 Alnylam Pharmaceuticals Revenue in RNA Medicine Business (2017-2023)
11.16.5 Alnylam Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
In Vitro Diagnostics Quality Control Market
Global In Vitro Diagnostics Quality Control Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Ileostomy Market
Global Ileostomy Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
Global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Human Papillomavirus Vaccine Market
Global Human Papillomavirus Vaccine Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hospital Acquired Pneumonia Drugs Market
Global Hospital Acquired Pneumonia Drugs Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast